Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a clinical-stage biopharmaceutical company developing ...

More than 100 students from Redcar and Cleveland College and Stockton Riverside College picked up their qualifications at ...

Detailed price information for Palisade Bio Inc (PALI-Q) from The Globe and Mail including charting and trades.

Icotrokinra demonstrated clinically meaningful outcomes at Week 28 in the Phase 2b ANTHEM-UC study in ulcerative colitis, with 31.7% of patients achieving clinical remission and 38.1% showing ...

Ventyx Biosciences' VTX3232 showed promising anti-inflammatory Phase 2 results, but financial risks remain. Click here to ...

Elizabeth Ann Dahl, 49, had led police officers on a “lengthy high-speed chase” through both Glenn and Butte Counties. The chase “only ended when Dahl nearly collided head-on with the vehicle of Chico ...

See how Teva Pharmaceutical Industries Limited's growth strategy and focus on specialty medicines are driving a turnaround.

For an accessible version of this Press Release, please visit Teva reports revenues of $4.5 billion in the third quarter of ...

Following constructive FDA feedback, Seres is finalizing its SER-155 Phase 2 study protocol for the prevention of bloodstream infections in adults undergoing allogeneic hematopoietic stem cell transpl ...

In January 2019, Locus entered a collaboration with Janssen Pharmaceuticals, one of Johnson & Johnson's companies, to develop ...

Eli Lilly and Novo Nordisk’s competition in weight-loss drugs has affected thousands of jobs between Charlotte and Raleigh. Who is winning?

Reported positive interim Phase 1 results for SPY003, a next-generation anti-IL-23 antibody, demonstrating the molecule was well-tolerated and ...